Treatment of rheumatic diseases in children: special considerations.
The goals of treatment of rheumatic diseases in children are to control the disease process while ensuring normal nutrition, growth, and development. The choice of antirheumatic drugs is similar in children and adults, but the doses, treatment schedules, and susceptibility to toxicity can differ considerably. In addition to differences between adult and pediatric diseases themselves, it is important for the rheumatologist who treats children to be cognizant of the impact of nutritional, developmental, and growth issues and differential susceptibility to toxicity of various treatments.
Milojevic
Diana S
DS
Division of Pediatric Rheumatology, Schneider Children's Hospital, Albert Einstein College of Medicine, 269-01 76th Avenue, Room CH191, New Hyde Park, NY 11040, USA.
Ilowite
Norman T
NT
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001846:Bone Development / Q000187:drug effects* / Q000502:physiology; D001847:Bone Diseases / Q000209:etiology; D002648:Child; D015362:Child Nutrition Disorders / Q000209:etiology; D002664:Child Nutritional Physiological Phenomena / Q000502:physiology*; D006128:Growth / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007107:Immune System / Q000187:drug effects* / Q000503:physiopathology; D007154:Immune System Diseases / Q000209:etiology; D007155:Immunologic Factors / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D013256:Steroids
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D013256:Steroids